Schizophrenia is a severe psychiatric illness characterised by disturbance of thought, hallucination and delusions.
Schizophrenia is a severe psychiatric illness characterised by disturbance of thought, hallucinations and delusions. Family, twin and adoption studies strongly evidenced genetic susceptibility and a pattern of inheritance belonging to the class of multifactorial complex disorders. 1 Many hypotheses have been made to explain the pathophysiology of schizophrenia and several studies suggest that dysfunctions in metabolism of neurotransmitters, such as dopamine, serotonin and glutamate, are directly implicated in the pathogenesis of this severe illness. A growing number of studies focused the attention on dysfunctions in glutamatergic pathway as a major susceptibility factor for schizophrenia. 2 Glutamate receptors are widely expressed in the central nervous system and play a fundamental role in synaptic plasticity and in all the processes underlying learning and memory. In particular the calcium influx through ionotropic glutamate receptors influences the regulation of transcriptional, translational and posttranslational processes fundamental for the function of brain cells. 3 One of the hypotheses about the molecular mechanisms leading to schizophrenia is the presence of an excessive activation of glutamate receptors. An increase in the basic metabolic activity along the glutamatergic axons has been demonstrated by PET scan studies in the cingulate cortex and hippocampal region of schizophrenic patients. 4, 5 It has been hypothesised that this may cause a progressive excitotoxic cell death through the disruption of ionic gradients and the increase of intracellular calcium concentration. 6, 7 Numerous findings suggested that ionotropic receptors of the kainate subtype, composed by the low affinity subunits GRIK1, GRIK2, GRIK3, and the high affinity subunits GRIK4 and GRIK5, are candidates involved in the induction of excitotoxicity. 6, 8 The measurement of expression levels of the ionotropic glutamate receptors in different brain areas from schizophrenic patients and healthy controls showed a general decrease of KA subtype expression, except for the GRIK3 subunit that appears to be expressed at higher levels in schizophrenics than in controls. 9 The GRIK3 subunit shares the same structural organisation of all ionotropic receptors, consisting in an extracellular N-terminus, three transmembrane domains (TMDs) A, B and C, and an intracellular Cterminus. The pore-forming region is located between the TMDs A and B, and the ligand binding site comprises two polypeptide segments (S1 and S2). S1 domain is located in the N-terminus upstream of the TMD A and the S2 domain in the extracellular loop that joins the TMDs B and C. 10 Kainate receptors have at least one gln/arg (Q/R) post-transcriptional editing site and the change of the glutamine in an arginine in the pore-forming region of the protein reduces calcium permeability. GRIK3 contains a gln/arg site in position 352 of the protein sequence but it always remains unedited and it has been recently demonstrated that a second putative editing site is in fact a genetic polymorphism (T928G) and that the T→G variation leads to a serine→alanine change in position 310 in the extracellular N-terminus of the protein. 8, 11 Schiffer and colleagues have analysed the expression rates of the two GRIK3 allelic variants in different brain areas from heterozygous T/G healthy people and neuropsychiatric patients. In all the individuals there were large differences in the expression levels, but in general the T allele was more frequently associated with lower expression levels and the G allele was expressed at higher rates. They concluded that to date this is the first example of a genetic polymorphism that affects the primary structure of a human ionotropic glutamate receptor subunit. 8 We have assayed for functional differences in the amino acidic sequence of the two GRIK3 isoforms by using the proteomics tools ProtParam, Prosite, PREDATOR available on ExPASy web site (http://www.expasy.ch/) and the analysis showed no significant differences for almost all the biochemicalbiophysical parameters. Only the analysis of the instability index (II) showed a difference, and we found that ala310 had an II value of 39.08, suggesting that the protein is stable, and instead ser310 had a value of 40.26, suggesting protein instability. 12 To investigate the role of this polymorphism in schizophrenia we have analysed in a case-control association study the allele frequencies and the genotype distributions in a population of 99 schizophrenic patients and 116 unaffected controls. Allele frequencies, genotype distributions and the statistical analysis are shown in Table 1 . Both the populations were in Hardy-Weinberg equilibrium (P = 0.3556) and the allelic frequencies in our controls did not differ from data previously reported (P = 0.7761). 8 The allele frequency came close to statistical significance (P = 0.0694) with an excess of ala allele in schizophrenic patients. This excess was evidenced by the genotype distribution that was significantly different ( 2 = 7.98, P = 0.019). Furthermore considering ala allele as dominant the difference in the distribution was even more significant (P = 0.0105) with an OR = 2.031, 95% CI 1.177-3.504. This suggests that ser310ala dimorphism in the GRIK3 gene is associated with schizophrenia with a potential role of ala310 allele. These results and the relative stability of ala310 allele could explain an increase of GRIK3 expression found in schizophrenics brain. Furthermore it is possible that ala310 GRIK3 variant escapes the down-regulation occurring to the kainate receptors in schizophrenics' brain, and affects such functions as receptor desensitization or ligand binding with the same mechanism recently described for another ionotropic glutamate receptor, where a single amino acid substitution acts as dominant by completely blocking the desensitization of the entire receptor. [13] [14] [15] However further expression studies in vivo are required to clarify the function of these GRIK3 polymorphic variants.
In conclusion, these findings confirm the involvement of the ionotropic glutamate receptors in schizophrenia and suggest a specific role of the GRIK3 gene in the susceptibility to the disease.
Methods

Patients recruitment and clinical assessment
Ninety-nine schizophrenic patients, recruited from the Psychiatric Rehabilitation Centre IRCCS S Giovanni di Dio, Fatebenefratelli (Brescia, Italy), and 116 unrelated healthy controls gave written informed consent to participate in this study, as recommended by the Ethics Committee of the Centre. All the individuals were Caucasoid living in Northern Italy.
All the patients met the diagnostic criteria of DSM-IV for schizophrenia as diagnosed by two psychiatrists using the Structured Clinical Interview for DSM-IV Patient Edition (SCID-P). The Brief Psychiatric Rating Scale (BPRS) was used to evaluate symptoms.
Sample collection A 7-10 ml peripheral blood sample was collected from each individual and stored at −20°C before use.
Nucleic acid purification and PCR Genomic DNA was extracted from leukocytes according to a standard method (salting out). The GRIK3 (GenBank accession number U16127) single nucleotide polymorphism T/G in position 928 was screened by a PCR amplification followed by digestion with a restriction endonuclease. The primers used for the PCR were GRIK3-F (forward) 5Ј ATTCCGGATTCTCAATGTGG 3Ј and GRIK3-R (reverse) 5Ј GGGAGTTCACGG TCATCTGT 3Ј. PCR conditions were denaturation at 94°C for 5 min followed by 35 cycles at 94°C for 30 s, 58°C for 30 s, 72°C for 30 s with a final elongation step at 72°C for 5 min. The PCR products were digested overnight at 25°C with 5 units of the restriction endonuclease SmaI (Promega, Madison, WI, USA) and electrophoresed on a 2% agarose gel (Gibco BRL, Life Technologies, Paisley, UK).
Statistical analysis
The 2 test was performed to assess the significance of our results. The Hardy-Weinberg equilibrium in the two populations considered in this study was tested by using the 2 test for goodness of fit. Odds ratio (OR) and their 95% confidence intervals were calculated to evaluate the effects of different genotypes.
Protein prediction analysis
We analysed the structural and physical-chemical features of the ala310 and ser310 isoforms utilising the tools available on the ExPASy (Expert Protein Analysis System) proteomics server of the Swiss Institute of Bioinformatics (http://www.expasy.ch/).
